Strengthening India's Pharmaceutical Manufacturing Ecosystem

India's pharmaceutical manufacturing ecosystem continues to receive policy support with the introduction of the Haryana Pharmaceutical and Medical Devices Manufacturing Policy 2026. The policy aims to attract investments of approximately ₹10,000 crore over the next five years and generate around 20,000 employment opportunities, while strengthening domestic manufacturing capabilities across pharmaceuticals and medical devices.

The initiative seeks to encourage investments across the pharmaceutical value chain by promoting manufacturing infrastructure, innovation, and the production of high-value healthcare products. The policy also supports the broader objective of enhancing India's competitiveness as a global pharmaceutical manufacturing destination.

What stands out is not merely the announcement of a new policy, but the continued emphasis on expanding domestic manufacturing capacity and strengthening the healthcare manufacturing ecosystem. As investments in pharmaceutical infrastructure and medical devices increase, the sector may benefit from improved manufacturing capabilities, supply-chain development, and continued focus on innovation.

The development reflects the ongoing efforts aimed at strengthening India's pharmaceutical manufacturing ecosystem through policy support, investment promotion, and infrastructure development, reinforcing the country's long-term position in the global healthcare value chain.

Source: Times of India Data as on: 29th June 2026

*Portfolio allocation as on 30th June 2026. Allocations are subject to change based on portfolio positioning, investment decisions, and market conditions.

Disclaimer:

The information provided is for informational purposes only and should not be construed as investment advice or a recommendation to buy, sell, or hold any security or sector. Views are based on current market conditions and are subject to change without notice. Sectoral allocations and portfolio positioning may vary across schemes and are subject to change in accordance with the investment objective and market conditions. Past performance may or may not be sustained in future and is not a guarantee of future returns.

Entity Name: Motilal Oswal Mutual Fund | SEBI registered Number: MF/063/09/04

Mutual fund investments are subject to market risks, read all scheme related documents carefully.